• 1. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 2. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 3. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502

Introduction to 3-(aminomethyl)benzene-1-carboximidamide (CAS No. 73711-52-1)

3-(aminomethyl)benzene-1-carboximidamide, identified by the Chemical Abstracts Service Number (CAS No.) 73711-52-1, is a significant compound in the realm of pharmaceutical chemistry and bioorganic synthesis. This heterocyclic amide derivative has garnered attention due to its versatile structural framework, which positions it as a valuable intermediate in the development of novel therapeutic agents. The compound’s molecular architecture, featuring both an amine and an imidamide functional group, offers unique reactivity that can be leveraged in medicinal chemistry applications.

The aminomethyl substituent at the para position relative to the benzene ring introduces a nucleophilic site, making the molecule a potential precursor for further functionalization. This characteristic is particularly useful in constructing more complex scaffolds, such as those found in kinase inhibitors or protease inhibitors, which are critical targets in modern drug discovery. Additionally, the benzene-1-carboximidamide core provides a rigid planar structure that can enhance binding affinity and selectivity in protein-ligand interactions.

Recent advancements in computational chemistry have highlighted the role of 3-(aminomethyl)benzene-1-carboximidamide as a key building block in designing small-molecule modulators. Studies have demonstrated its efficacy in targeting enzymes involved in inflammatory pathways, such as cyclooxygenase (COX) and lipoxygenase (LOX). The imidamide moiety, in particular, has been shown to stabilize transition states through hydrogen bonding and electrostatic interactions, which are pivotal for achieving high enzymatic activity.

In vitro investigations have revealed that derivatives of 3-(aminomethyl)benzene-1-carboximidamide exhibit promising pharmacological properties. For instance, modifications at the amino group have led to compounds with enhanced solubility and improved pharmacokinetic profiles. These findings align with the broader trend in drug development towards rational design, where structural features are meticulously optimized to maximize therapeutic efficacy while minimizing side effects.

The synthesis of 3-(aminomethyl)benzene-1-carboximidamide typically involves multi-step organic transformations, including condensation reactions between appropriately substituted benzene derivatives and amidine precursors. Advances in synthetic methodologies have enabled more efficient and scalable production processes, making this compound more accessible for industrial applications. Techniques such as transition-metal-catalyzed cross-coupling reactions have further streamlined its preparation, allowing for greater flexibility in modifying its core structure.

From a biological perspective, the aminomethyl group serves as a linker that can connect different pharmacophoric units, facilitating the development of hybrid molecules with synergistic effects. This modular approach is particularly advantageous in tackling multifaceted diseases that require polypharmacological intervention. Moreover, the benzene ring’s aromaticity contributes to favorable electronic properties, influencing both metabolic stability and binding interactions.

Emerging research also explores the potential of 3-(aminomethyl)benzene-1-carboximidamide in non-pharmaceutical applications, such as material science and agrochemicals. Its ability to undergo selective functionalization makes it a candidate for designing novel polymers or specialty chemicals with tailored properties. Such interdisciplinary applications underscore the compound’s broad utility beyond traditional medicinal chemistry contexts.

The regulatory landscape for compounds like 3-(aminomethyl)benzene-1-carboximidamide is shaped by guidelines that emphasize safety and environmental responsibility. Manufacturers must adhere to stringent quality control measures to ensure consistency and purity throughout production. Collaborative efforts between academia and industry continue to refine synthetic protocols, aiming to reduce waste and improve sustainability while maintaining high chemical yields.

Future directions in research may focus on exploring enantioselective synthesis methods to develop chiral derivatives of 3-(aminomethyl)benzene-1-carboximidamide. Enantiopure compounds often exhibit distinct biological activities, making them highly sought after in drug development. Catalytic asymmetric processes could provide an elegant solution to this challenge, offering a sustainable path forward for producing enantiomerically enriched materials.

In summary,3-(aminomethyl)benzene-1-carboximidamide (CAS No. 73711-52-1) represents a compelling subject of study due to its structural versatility and functional diversity. Its role as an intermediate in pharmaceutical synthesis underscores its importance in addressing contemporary challenges in medicine and biotechnology. As research progresses, this compound is poised to contribute significantly to innovation across multiple scientific disciplines.

• 6326-27-8(4-Methylbenzimidamide hydrochloride)
• 206752-36-5(Benzamidine Hydrochloride Hydrate)
• 26130-48-3(3,5-dimethylbenzene-1-carboximidamide)
• 123920-06-9(b-allo-2-Octulopyranose,2,7-anhydro-1,4,8-trideoxy-5-O-(phenylmethyl)- (9CI))
• 18465-28-6(3-Methylbenzenecarboximidamide)
• 20680-59-5(3-Methylbenzenecarboximidamide Hydrochloride)
• 1670-14-0(benzenecarboximidamide hydrochloride)
• 15411-54-8(benzene-1,4-dicarboximidamide)
• 14805-64-2(Naphthalene-1-carboxamidine)
• 18465-11-7(4-Methylbenzenecarboximidamide)